Valproic Acid in Combination With Bevacizumab and Oxaliplatin/Fluoropyrimidine Regimens in Patients With Ras-mutated Metastatic Colorectal Cancer
Clinical trial NCT04310176 · UNKNOWN
Trial details
- NCT number
- NCT04310176
- Sponsor
- National Cancer Institute, Naples
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-24
- Primary completion
- 2023-12-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.